Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: RS Group director raises stake

(Sharecast News) - RS Group revealed on Thursday that non-executive director David Sleath had acquired 4,883 ordinary shares in the FTSE 250-listed industrial and electrical products distributor. Sleath, who joined RS Group in June 2019, purchased the shares on Wednesday at an average price of 570.50p each, for a total value of £27,857.47.

As of 1620 BST, RS Group shares were flat at 571.50p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Atome (ATOM) Director name: Levine,Peter M Amount purchased: 800,000 @ 50.00p Value: £400,000.00

Atome (ATOM) Director name: Mussat,Olivier Charles Frederic Amount purchased: 507,698 @ 50.00p Value: £253,849.00

Atome (ATOM) Director name: (Hellmers),James E C Spalding Amount purchased: 375,940 @ 50.00p Value: £187,970.00

Atome (ATOM) Director name: Levine,Nikita Petrovich Amount purchased: 124,000 @ 50.00p Value: £62,000.00

Atome (ATOM) Director name: Levine,Nikita Petrovich Amount purchased: 124,000 @ 50.00p Value: £62,000.00

Rs Group (RS1) Director name: Sleath,David J R Amount purchased: 4,883 @ 570.50p Value: £27,857.47

Atome (ATOM) Director name: Sheffrin,Robert Anthony Amount purchased: 30,000 @ 50.00p Value: £15,000.00

Top Director Sells

Bp (BP.) Director name: Auchincloss,Murray Amount sold: 336,621 @ 359.47p Value: £1,210,063.66

Share this article

Related Sharecast Articles

Director dealings: Eurocell chairman raises stake
(Sharecast News) - Eurocell revealed on Thursday that non-executive chairman Derek Mapp had acquired 21,325 ordinary shares in the London-listed building products manufacturer.
Director dealings: Greatland Gold director lowers stake
(Sharecast News) - Greatland Gold revealed on Wednesday that non-executive director Alexander Borrelli had disposed of 526,880 ordinary shares in the AIM-listed gold and copper miner.
Director dealings: Genedrive CEO raises stake
(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
Director dealings: Watkin Jones chairman raises shareholding
(Sharecast News) - Watkin Jones revealed on Friday that non-executive chair Alan Giddins had acquired 50,000 ordinary shares in the AIM-listed developer.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.